On March 15, 2019 Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or "the Company") reported that it will present a corporate overview at the Oppenheimer & Co. 29th Annual Healthcare Conference, being held March 19-20 at the Westin Grand Central Hotel in New York City (Press release, Actinium Pharmaceuticals, MAR 15, 2019, View Source [SID1234534391]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Date:

Wednesday, March 20

Time:

1:35 pm Eastern Time

Room:

Consulate

Venue:

Westin Grand Central Hotel

212 East 42nd St, New York City

(PRNewsfoto/Actinium Pharmaceuticals, Inc.)

Management will be conducting 1-on-1 meetings with conference attendees. Meetings with Actinium can be scheduled by emailing Steve O’Loughlin, Principal Financial Officer: [email protected].